Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) today announced key highlights from its Grand Rounds presentation (to ...
A sponsor will have to demonstrate success with "with several consecutive patients with different bespoke therapies" to ...